KALV – kalvista pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
KalVista Pharmaceuticals Announces New England Journal of Medicine Publishes Oral Sebetralstat Phase 3 Data Demonstrating its Potential to Transform the Treatment Landscape for People with Hereditary Angioedema [Yahoo! Finance]
KalVista Pharmaceuticals Announces New England Journal of Medicine Publishes Oral Sebetralstat Phase 3 Data Demonstrating its Potential to Transform the Treatment Landscape for People with Hereditary Angioedema
KalVista Pharmaceuticals Announces Ten Abstracts Accepted for Presentation at the European Academy of Allergy and Clinical Immunology Congress 2024 [Yahoo! Finance]
KalVista Pharmaceuticals Announces Ten Abstracts Accepted for Presentation at the European Academy of Allergy and Clinical Immunology Congress 2024
Breakeven On The Horizon For KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) [Yahoo! Finance]
Form 4 KalVista Pharmaceuticals For: May 22 Filed by: Yea Christopher
Form 4 KalVista Pharmaceuticals For: May 22 Filed by: Audhya Paul K.
Form 4 KalVista Pharmaceuticals For: May 17 Filed by: Feener Edward P.
Form 4 KalVista Pharmaceuticals For: May 17 Filed by: Audhya Paul K.
Form 4 KalVista Pharmaceuticals For: May 17 Filed by: Palleiko Benjamin L
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.